A comparative study on the efficacy of artesunate plus sulphadoxine/ pyrimethamine versus artemether-lumefantrine in eastern Sudan

Malaria Journal

Volumn 6, Issue , 2007, Pages

  Mukhtar, Ebtihal A ^a   Gadalla, Nahla B ^a   El Zaki, Salah Eldin G ^a   Mukhtar, Izdihar ^a   Mansour, Fathi A ^a   Babiker, Ahmed ^a   El Sayed, Badria B ^a  

^a TROPICAL MEDICINE RESEARCH INSTITUTE   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; FANSIDAR; ANTIMALARIAL AGENT; ARTEMETHER LUMEFANTRINE COMBINATION; ARTEMETHER-LUMEFANTRINE COMBINATION; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2, PLASMODIUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PYRIMETHAMINE; SESQUITERPENE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; GENE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MSP 1 GENE; MSP 2 GENE; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; REINFECTION; SUDAN; TREATMENT OUTCOME; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION; ANIMAL; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; GENETICS; MALARIA; PARASITOLOGY; PLASMODIUM FALCIPARUM;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, PROTOZOAN; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; GENOTYPE; HUMANS; MALARIA; MALE; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; PYRIMETHAMINE; SESQUITERPENES; SUDAN; SULFADOXINE; TREATMENT OUTCOME;

EID: 34547763288     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-6-92     Document Type: Article

References (23)

1. Malaria in Sudan: past, present and the future. EM Malik O.M., Khalafalla, Gezira Journal of Health Sciences 2004 1 Supplement 47 51
2. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. HA Babiker SJ Pringle A Abdel-Muhsin M Mackinnon P Hunt D Walliker, J Infect Dis 2001 183 10 1535 1538 10.1086/320195 11319692
3. Resistance of P. falciparum to antimalarial drugs in Sudan. EMI Adam I, Khartoum Med J 2005
4. A randomized comparison of sulphadoxine-pyrimethamine and combination of sulphadoxine pyrimethamine with chloroquine in the treatment of uncomplicated falciparum malaria in Eastern Sudan. MT Salah MM Mohammed YE Himeidan EM Malik MI Elbashir I Adam, Saudi Med J 2005 26 1 147 148 15756376
5. From chloroquine to artemisinin-based combination therapy: the Sudanese experience. EM Malik TA Mohamed KA Elmardi RM Mowien AH Elhassan SB Elamin AA Mannan ES Ahmed, Malar J 2006 5 65 16879742 10.1186/1475-2875-5-65
6. Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan. I Adam DM Ali MA Abdalla, Trans R Soc Trop Med Hyg 2006 100 7 632 635 10.1016/j.trstmh.2005.09.019 16436287
7. Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan. SB Elamin EM Malik T Abdelgadir AH Khamiss MM Mohammed ES Ahmed I Adam, Malar J 2005 4 41 16162284 10.1186/1475-2875-4-41
8. The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan. AO Mohamed EH Eltaib OA Ahmed SB Elamin EM Malik, Ann Trop Med Parasitol 2006 100 1 5 10 10.1179/136485906X86239 16417707
9. Efficacies of artesunate plus either sulfadoxinepyrimethamine or amodiaquine, for the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. AM Ibrahium MM Kheir ME Osman IF Khalil M Alifrangis KA Elmardi EM Malik I Adam, Annals of Tropical Medicine and Parasitology 2007 101 15 21 10.1179/136485907X156924
10. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated malaria. WHO, 2003
11. Excel sheet for Resistance Data Collection and analysis. WHO, http://www.who.int/malaria/rbm/Attachment/20041108/resistance_datacollection. xls 2097487
12. A Longitudinal Study of Type-Specific Antibody Responses to Plasmodium falciparum Merozoite Surface Protein-1 in an Area of Unstable Malaria in Sudan. DR Cavanagh IM Elhassan C Roper VJ Robinson H Giha AA Holder L Hviid TG Theander DE Arnot JS McBride, J Immunol 1998 161 1 347 359 9647243
13. Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. F Ntoumi H Contamin C Rogier S Bonnefoy JF Trape O Mercereau-Puijalon, Am J Trop Med Hyg 1995 52 1 81 88 7856831
14. No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. J Zwetyenga C Rogier A Tall D Fontenille G Snounou JF Trape O Mercereau-Puijalon, Am J Trop Med Hyg 1998 59 5 726 735 9840589
15. Plasmodium falciparum: In Vitro Studies of the Pharmacodynamic Properties of Drugs Used for the Treatment of Severe Malaria. F Terkuile NJ White P Holloway G Pasvol S Krishna, Experimental Parasitology 1993 76 1 85 95 10.1006/expr.1993.1010 8467901
16. High frequency of Plasmodium falciparum PfCRT K76T and PfpghN86Y in patients clearing infection after chloroquine treatment in the Sudan. N Tagelsir Z Ibrahim A Medani O Salih A Hamad H Giha A El-Agib B Khan N Saeed M Ibrahim, Acta Trop 2006 97 1 19 25 10.1016/j.actatropica.2005.07.030 16171768
17. A comparison of the efficacy of artesunate plus sulfadoxine-pyrimethamine with that of sulfadoxine-pyrimethamine alone, in the treatment of uncomplicated, Plasmodium falciparum malaria in eastern Sudan. I Adam AE IE SM Idris EM Malik MI Elbashir, Ann Trop Med Parasitol 2005 99 5 449 455 10.1179/136485905X36299 16004704
18. Evolution of drug-resistance genes in Plasmodium falciparum in an area of seasonal malaria transmission in Eastern Sudan. AM Abdel-Muhsin MJ Mackinnon E Ali KA Nassir el S Suleiman S Ahmed D Walliker HA Babiker, J Infect Dis 2004 189 7 1239 1244 10.1086/382509 15031793
19. The Impact of clearing asymptomatic Plasmodium falciparum parasitaemia on drug resistance genes in an area of seasonal transmission in Sudan. N Gadalla Salah Eldin Elzaki, Ebtihal Mukhtar, Fathi Mansour, Izdihar Mukhtar, Amal Gadalla, Ahmed Babiker, Badria B. El Sayed, International Conference for Parasitology, ICOPA Glasgow, U.K. 2006
20. Selection of Plasmodium falciparum pfmdr1 Alleles following Therapy with Artemether-Lumefantrine in an Area of Uganda where Malaria Is Highly Endemic. C Dokomajilar SL Nsobya B Greenhouse PJ Rosenthal G Dorsey, Antimicrob Agents Chemother 2006 50 5 1893 1895 16641472 10.1128/AAC.50.5.1893-1895.2006
21. Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. GS Humphreys I Merinopoulos J Ahmed CJ Whitty TK Mutabingwa CJ Sutherland RL Hallett, Antimicrob Agents Chemother 2007 51 3 991 997 17194834 10.1128/AAC.00875-06
22. In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). C Sisowath J Stromberg A Martensson M Msellem C Obondo A Bjorkman JP Gil, J Infect Dis 2005 191 6 1014 1017 10.1086/427997 15717281
23. Tolerance is the key to understanding antimalarial drug resistance. IM Hastings WM Watkins, Trends in Parasitology 2006 22 2 71 77 10.1016/j.pt.2005. 12.011 16406706